Monte Rosa Therapeutics Inc (GLUE)
Operating Income Growth
-215.87%
Quarterly · Period ending:
GLUE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-215.87%period ending
Latest reported-215.87%period ending
GLUE Quarterly Operating Income YoY % (-167.97% → -215.87%)
Year-over-year change
High-resolution chart · PNG
GLUE operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -215.8673% | |
| -213.6207% | |
| -482.3054% | |
| -24.3073% | |
| 52.3497% | |
| 226.008% | |
| 137.3003% | |
| 28.2433% | |
| 12.3022% | |
| -2.0082% | |
| -7.3071% | |
| -30.3434% | |
| -36.6861% | |
| -40.9719% | |
| -38.9191% | |
| -42.7522% | |
| -50.2566% | |
| -111.2483% | |
| -95.9367% | |
| -211.1181% | |
| -235.8599% | |
| -167.9711% |